Classification of breast cancers according to the expression of the receptors ER (estrogen receptor) and HER2 (human epidermal growth factor receptor 2) has helped to describe clinically relevant sub-types of breast cancers and has been instrumental in devising successful targeted therapies [2]. This evidence concerns the gene ESR1 and breast cancer.